We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Simple Contrast Ultrasound Scan Overcomes MR and CT Limitations in Diagnosing Tumors

By MedImaging International staff writers
Posted on 11 Sep 2023
Print article
Image: Simple contrast ultrasound scan resolves indeterminate MR and CT (Photo courtesy of Freepik)
Image: Simple contrast ultrasound scan resolves indeterminate MR and CT (Photo courtesy of Freepik)

Contrast-enhanced ultrasound (CEUS) takes traditional ultrasound imaging up a notch and is widely applied globally for diagnosing heart conditions and assessing the risk of heart attacks or strokes. CEUS also plays a role in identifying and assessing tumors in various organs like the liver, kidney, prostate, and breast, as well as in tracking the efficacy of cancer treatments. Unlike other imaging techniques, CEUS employs non-radioactive ultrasound contrast agents, also known as UCAs or UEAs, to enhance the quality and reliability of standard ultrasound images. The high-resolution, real-time images produced by CEUS often match the quality of those obtained from CT or MR scans. Moreover, ultrasound equipment is not only less costly than other diagnostic imaging tools like MRIs and CTs but is also portable, readily available, and can be taken directly to a patient's bedside if necessary.

CEUS can also be an invaluable resource for clarifying ambiguous MR and CT scan results, according to Dr. Stephanie Wilson, a clinical professor of radiology and gastroenterology at the University of Calgary (Alberta, Canada) and Co-President of the International Contrast Ultrasound Society (ICUS, Chicago, IL, USA). The ultrasound contrast agents used in CEUS consist of suspensions of tiny injectable "microbubbles" that pose no known risk of kidney damage, brain contrast deposit, or ionizing radiation exposure for patients and healthcare providers alike. These microbubbles remain within blood vessels and do not go into the tissue, thereby offering highly accurate blood flow details when compared to interstitial agents used in CT and MR imaging. This level of detail in blood flow is vital for diagnosing and characterizing tumors as well as for detecting recurrences post-treatment, she noted.

“CEUS often overcomes limitations of MR and CT in diagnosing many tumors and detecting their recurrence,” said Dr. Wilson. “CEUS scans are significantly less expensive than MR and CT.”

“In addition, in cystic neoplasms anywhere in the body, including the liver, small deposits of tumor are detected on high resolution CEUS with superior sensitivity when compared to MR, which doesn’t even show the nodule or blood flow,” Dr. Wilson added. “Further, for liver imaging, CEUS overcomes MR limitations associated with fat and iron.”

Related Links:
University of Calgary 
ICUS 

Wall Fixtures
MRI SERIES
New
Specimen Radiography System
Trident HD
X-ray Diagnostic System
FDX Visionary-A
Portable Color Doppler Ultrasound System
S5000

Print article

Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.